Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, hurdles that include availability and cost remain to its widespread ...

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Non-Hodgkin lymphoma outcomes are linked to hemoglobin ... A study of 145 patients with primary extranodal NHL showed most cases were B-cell phenotypes, treated mainly with immunochemotherapy.

Firi-cel was being tested in a potentially pivotal Phase 2 trial enrolling patients with relapsed or refractory large B-cell lymphoma (LBCL) that had progressed following treatment with a CD19 ...

Medically reviewed by Doru Paul, MD Immunohistochemistry (IHC) is a special test used by pathologists to detect specific ...